Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 98 of the 99 references it cites were found in a registry or an index.

Encapsulation of β-NGF in injectable microrods for localized delivery accelerates endochondral fracture repair

Open access

Published version of a preprint

Abstract

Introduction: Currently, there are no non-surgical FDA-approved biological approaches to accelerate fracture repair. Injectable therapies designed to stimulate bone healing represent an exciting alternative to surgically implanted biologics, however, the translation of effective osteoinductive therapies remains challenging due to the need for safe and effective drug delivery. Hydrogel-based microparticle platforms may be a clinically relevant solution to create controlled and localized drug delivery to treat bone fractures. Here, we describe poly (ethylene glycol) dimethacrylate (PEGDMA)-based microparticles, in the shape of microrods, loaded with beta nerve growth factor (β-NGF) for the purpose of promoting fracture repair. Methods: Herein, PEGDMA microrods were fabricated through photolithography. PEGDMA microrods were loaded with β-NGF and in vitro release was examined. Subsequently, bioactivity assays were evaluated in vitro using the TF-1 tyrosine receptor kinase A (Trk-A) expressing cell line. Finally, in vivo studies using our well-established murine tibia fracture model were performed and a single injection of the β-NGF loaded PEGDMA microrods, non-loaded PEGDMA microrods, or soluble β-NGF was administered to assess the extent of fracture healing using Micro-computed tomography (µCT) and histomorphometry. Results: In vitro release studies showed there is significant retention of protein within the polymer matrix over 168 hours through physiochemical interactions. Bioactivity of protein post-loading was confirmed with the TF-1 cell line. In vivo studies using our murine tibia fracture model show that PEGDMA microrods injected at the site of fracture remained adjacent to the callus for over 7 days. Importantly, a single injection of β-NGF loaded PEGDMA microrods resulted in improved fracture healing as indicated by a significant increase in the percent bone in the fracture callus, trabecular connective density, and bone mineral density relative to soluble β-NGF control indicating improved drug retention within the tissue. The concomitant decrease in cartilage fraction supports our prior work showing that β-NGF promotes endochondral conversion of cartilage to bone to accelerate healing. Discussion: We demonstrate a novel and translational method wherein β-NGF can be encapsulated within PEGDMA microrods for local delivery and that β-NGF bioactivity is maintained resulting in improved bone fracture repair.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fbioe.2023.1190371

Cites

98 of 98 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIGURE 1 Schematic of PEGDMA microrod fabrication via photolithography.
FIGURE 1 Schematic of PEGDMA microrod fabrication via photolithography.CC BY · PubMed Central
FIGURE 2 PEGDMA microrods are readily protein loaded. (A) Mass in 16,000 (16K) microrods. (B) Percent release of β-NGF from 16K 75 and 90% (v/v) PEGDMA microrods (n = 3). (C) β-NGF released (in ng) from 75 and 90% microrods after treatment with PBS, 1M NaCl, or 1 M Urea for 2 h. *p < 0.05 determined by Two-way ANOVA with Tukey’s post hoc test for multiple comparisons (n = 3). (D) DAPI-loaded 90% PEGDMA microrods, scale bar = 250 µm.
FIGURE 2 PEGDMA microrods are readily protein loaded. (A) Mass in 16,000 (16K) microrods. (B) Percent release of β-NGF from 16K 75 and 90% (v/v) PEGDMA microrods (n = 3). (C) β-NGF released (in ng) from 75 and 90% microrods after treatment with PBS, 1M NaCl, or 1 M Urea for 2 h. *p < 0.05 determined by Two-way ANOVA with Tukey’s post hoc test for multiple comparisons (n = 3). (D) DAPI-loaded 90% PEGDMA microrods, scale bar = 250 µm.CC BY · PubMed Central
FIGURE 3 β-NGF loaded into PEGDMA microrods retain bioactivity and increased cell number. PEGDMA microrods were incubated in cell media for 168 hours and the media was collected and used to treat the cells for 40 hours. Fold change in TF-1 cell number for each experimental group is relative to the media only treated cells. Error bars represent SD, *p < 0.05 determined by ANOVA with Tukey’s post hoc test for multiple comparisons (n = 3).
FIGURE 3 β-NGF loaded into PEGDMA microrods retain bioactivity and increased cell number. PEGDMA microrods were incubated in cell media for 168 hours and the media was collected and used to treat the cells for 40 hours. Fold change in TF-1 cell number for each experimental group is relative to the media only treated cells. Error bars represent SD, *p < 0.05 determined by ANOVA with Tukey’s post hoc test for multiple comparisons (n = 3).CC BY · PubMed Central
FIGURE 4 Localization of PEGDMA microrods within tibial fracture calluses. Representative micrographs of (A) low and (B) high magnification of HBQ-stained fracture calluses 5 days post-microrod injection. Representative micrographs of (C) low and (D) high magnification of fracture calluses 7 days postmicrorod injection. Arrows indicate PEGDMA microrods within calluses. (A,C) Scale bars = 1 mm, (B,D) Scale bars = 100 µm. (E) Representative micrograph of fracture callus 14 days post-injection, scale bar = 1 mm.
FIGURE 4 Localization of PEGDMA microrods within tibial fracture calluses. Representative micrographs of (A) low and (B) high magnification of HBQ-stained fracture calluses 5 days post-microrod injection. Representative micrographs of (C) low and (D) high magnification of fracture calluses 7 days postmicrorod injection. Arrows indicate PEGDMA microrods within calluses. (A,C) Scale bars = 1 mm, (B,D) Scale bars = 100 µm. (E) Representative micrograph of fracture callus 14 days post-injection, scale bar = 1 mm.CC BY · PubMed Central
FIGURE 5 Micro-computed tomography (μCT) analysis of newly formed bone within fracture calluses. Representative three-dimensional images of tibial fracture calluses from mice treated 14 days post-fracture with (A) saline as controls (B) single dose of β-NGF (2000ng) (C) non-loaded PEGDMA microrods and (D) PEGDMA microrods loaded with β-NGF. Scale bars = 1 mm. Quantification of (E) bone volume fraction (F) trabecular connective density and (G) bone mineral density. Error bars represent SD, * p < 0.05, ** p < 0.01 determined by ANOVA with Tukey’s post hoc test for multiple comparisons.
FIGURE 5 Micro-computed tomography (μCT) analysis of newly formed bone within fracture calluses. Representative three-dimensional images of tibial fracture calluses from mice treated 14 days post-fracture with (A) saline as controls (B) single dose of β-NGF (2000ng) (C) non-loaded PEGDMA microrods and (D) PEGDMA microrods loaded with β-NGF. Scale bars = 1 mm. Quantification of (E) bone volume fraction (F) trabecular connective density and (G) bone mineral density. Error bars represent SD, * p < 0.05, ** p < 0.01 determined by ANOVA with Tukey’s post hoc test for multiple comparisons.CC BY · PubMed Central
FIGURE 6 Single injections of PEGDMA microrods loaded with β-NGF promote endochondral bone repair. (A) Representative micrographs of HBQ-stained fracture calluses from mice 14 days post-fracture treated with saline as controls, single dose of soluble β-NGF (2000ng), non-loaded PEGDMA microrods, or PEGDMA microrods loaded with β-NGF. Upper row scale bars = 2mm, middle and lower row scale bars = 500 µm. Quantification of (B) cartilage percentage (cartilage volume/total volume), (C) absolute cartilage volume, (D) bone percentage (bone volume/total volume), (E) absolute bone volume, (F) fibrous percentage (fibrous volume/total volume), and (G) total callus volume. Error bars represent SD, *p < 0.05 determined by ANOVA with Tukey’s post hoc test for multiple comparisons.
FIGURE 6 Single injections of PEGDMA microrods loaded with β-NGF promote endochondral bone repair. (A) Representative micrographs of HBQ-stained fracture calluses from mice 14 days post-fracture treated with saline as controls, single dose of soluble β-NGF (2000ng), non-loaded PEGDMA microrods, or PEGDMA microrods loaded with β-NGF. Upper row scale bars = 2mm, middle and lower row scale bars = 500 µm. Quantification of (B) cartilage percentage (cartilage volume/total volume), (C) absolute cartilage volume, (D) bone percentage (bone volume/total volume), (E) absolute bone volume, (F) fibrous percentage (fibrous volume/total volume), and (G) total callus volume. Error bars represent SD, *p < 0.05 determined by ANOVA with Tukey’s post hoc test for multiple comparisons.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 22

Metadata

Authors
Rivera, K. O., Cuylear, D. L., Duke, V. R., O’Hara, K. M., Zhong, J. X., Elghazali, N. A., Finbloom, J. A., Kharbikar, B. N., Kryger, A. N., Miclau, T., Marcucio, R. S., Bahney, C. S., & Desai, T. A.
Affiliations
  • University of California, San Francisco (US)
  • Steadman Philippon Research Institute (US)
Corresponding author
Desai, Tejal A.
Venue
Frontiers in Bioengineering and Biotechnology
Published
2023-05-22
Volume
11
Pages
1190371-1190371
ISSN
2296-4185 (ISSN-L)
OpenAlex
W4377287917
Cited by
22
References
99
Citations by year
2026: 7 · 2025: 7 · 2024: 6 · 2023: 1
FWCI
1.66
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Bioengineering and Biotechnology (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • eScholarship (California Digital Library) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases
  • National Institute of Dental and Craniofacial Research
  • National Institute of General Medical Sciences
Topics
  • Physical Sciences › Engineering › Biomedical Engineering › Bone Tissue Engineering Materials
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone fractures and treatments
  • Physical Sciences › Materials Science › Biomaterials › Hydrogels: synthesis, properties, applications
Keywords
beta-nerve growth factor, injectable drug delivery, fracture healing, hydrogel microparticles, protein encapsulation, callus formation, bone regeneration

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.